ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS

Non-steroidal anti-inflammatory drugs (NSAIDs) are liders in selling both in the Russian Federation and worldwide. The combination of  analgesic, anti-inflammatory and antipyretic effects make the drugs  of this group very popular in patients with various diseases. The  realization of NSAIDs in phar...

Full description

Saved in:
Bibliographic Details
Main Authors: N. Yu. Velts, T. M. Bukatina, E. O. Zhuravleva, G. V. Kutekhova, M. A. Darmostukova, Yu. V. Olefir, B. K. Romanov, S. V. Glagolev, V. A. Polivanov
Format: Article
Language:Russian
Published: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2018-09-01
Series:Безопасность и риск фармакотерапии
Subjects:
Online Access:https://www.risksafety.ru/jour/article/view/113
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849343334483492864
author N. Yu. Velts
T. M. Bukatina
E. O. Zhuravleva
G. V. Kutekhova
M. A. Darmostukova
Yu. V. Olefir
B. K. Romanov
S. V. Glagolev
V. A. Polivanov
author_facet N. Yu. Velts
T. M. Bukatina
E. O. Zhuravleva
G. V. Kutekhova
M. A. Darmostukova
Yu. V. Olefir
B. K. Romanov
S. V. Glagolev
V. A. Polivanov
author_sort N. Yu. Velts
collection DOAJ
description Non-steroidal anti-inflammatory drugs (NSAIDs) are liders in selling both in the Russian Federation and worldwide. The combination of  analgesic, anti-inflammatory and antipyretic effects make the drugs  of this group very popular in patients with various diseases. The  realization of NSAIDs in pharmacies occurs both by prescription and  over-the-counter, so the safety assessment of the use of this group  of drugs remains relevant. In the current practice, self-administration (responsible selfmedication) of drugs of the NSAID  group is an additional factor affecting the safety of their intake. According to the studies, about 40 % of patients taking  NSAIDs consider that NSAIDS are absolutely safe, and more than 30  % of those taking OTC NSAIDs use them in excess of the  recommended dosages. We analyzed 3963 individual case safety  reports (ICSR) in the federal database «Pharmacovigilance» from  07.12.2008 to 31.08.2017. The inclusion criterions was the presence of information on the off-label application of NSAIDs in the ICSR,  reports of adverse effects that may be associated with the use of this drug or erroneous reports on the active substance, which was  not present in this drug. The most frequent mistakes in the  application were an increase of the daily dose, a change in the  method of administration to patient who are contraindicated with this drug. There were 9 ICSR of burning sensation in the anus with the  introduction of ibuprofen suppositories (not in the label), and 7 ICSR  of ineffectiveness of the active substance, which was not present in this drug.
format Article
id doaj-art-b3869af2c9fe40c2b3003e88c81032d6
institution Kabale University
issn 2312-7821
2619-1164
language Russian
publishDate 2018-09-01
publisher Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
record_format Article
series Безопасность и риск фармакотерапии
spelling doaj-art-b3869af2c9fe40c2b3003e88c81032d62025-08-20T03:43:01ZrusMinistry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»Безопасность и риск фармакотерапии2312-78212619-11642018-09-016312312910.30895/2312-7821-2018-6-3-123-129112ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGSN. Yu. Velts0T. M. Bukatina1E. O. Zhuravleva2G. V. Kutekhova3M. A. Darmostukova4Yu. V. Olefir5B. K. Romanov6S. V. Glagolev7V. A. Polivanov8Scientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsFederal Service for Surveillance in Healthcare (Roszdravnadzor)Federal State Dudgetary Institution «Information and Methodological Centre for Expert Evaluation, Recording and Analysis of Circulation of Medicinal Products» of RoszdravnadzorNon-steroidal anti-inflammatory drugs (NSAIDs) are liders in selling both in the Russian Federation and worldwide. The combination of  analgesic, anti-inflammatory and antipyretic effects make the drugs  of this group very popular in patients with various diseases. The  realization of NSAIDs in pharmacies occurs both by prescription and  over-the-counter, so the safety assessment of the use of this group  of drugs remains relevant. In the current practice, self-administration (responsible selfmedication) of drugs of the NSAID  group is an additional factor affecting the safety of their intake. According to the studies, about 40 % of patients taking  NSAIDs consider that NSAIDS are absolutely safe, and more than 30  % of those taking OTC NSAIDs use them in excess of the  recommended dosages. We analyzed 3963 individual case safety  reports (ICSR) in the federal database «Pharmacovigilance» from  07.12.2008 to 31.08.2017. The inclusion criterions was the presence of information on the off-label application of NSAIDs in the ICSR,  reports of adverse effects that may be associated with the use of this drug or erroneous reports on the active substance, which was  not present in this drug. The most frequent mistakes in the  application were an increase of the daily dose, a change in the  method of administration to patient who are contraindicated with this drug. There were 9 ICSR of burning sensation in the anus with the  introduction of ibuprofen suppositories (not in the label), and 7 ICSR  of ineffectiveness of the active substance, which was not present in this drug.https://www.risksafety.ru/jour/article/view/113non-steroidal anti-inflammatory drugsoff-labelover-the-counter drugsdrug safetypharmacovigilance
spellingShingle N. Yu. Velts
T. M. Bukatina
E. O. Zhuravleva
G. V. Kutekhova
M. A. Darmostukova
Yu. V. Olefir
B. K. Romanov
S. V. Glagolev
V. A. Polivanov
ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
Безопасность и риск фармакотерапии
non-steroidal anti-inflammatory drugs
off-label
over-the-counter drugs
drug safety
pharmacovigilance
title ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
title_full ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
title_fullStr ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
title_full_unstemmed ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
title_short ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
title_sort on the issue of safety of non steroidal anti inflammatory drugs
topic non-steroidal anti-inflammatory drugs
off-label
over-the-counter drugs
drug safety
pharmacovigilance
url https://www.risksafety.ru/jour/article/view/113
work_keys_str_mv AT nyuvelts ontheissueofsafetyofnonsteroidalantiinflammatorydrugs
AT tmbukatina ontheissueofsafetyofnonsteroidalantiinflammatorydrugs
AT eozhuravleva ontheissueofsafetyofnonsteroidalantiinflammatorydrugs
AT gvkutekhova ontheissueofsafetyofnonsteroidalantiinflammatorydrugs
AT madarmostukova ontheissueofsafetyofnonsteroidalantiinflammatorydrugs
AT yuvolefir ontheissueofsafetyofnonsteroidalantiinflammatorydrugs
AT bkromanov ontheissueofsafetyofnonsteroidalantiinflammatorydrugs
AT svglagolev ontheissueofsafetyofnonsteroidalantiinflammatorydrugs
AT vapolivanov ontheissueofsafetyofnonsteroidalantiinflammatorydrugs